Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance.
The week at Retraction Watch featured:
- The top retractions of 2019;
- Two retractions and three corrections by an award-winning researcher;
- The retraction of a neuroscience paper from Science.
Here’s what was happening elsewhere:
- A Nigerian “commission discovered about 100 fake professors in the universities system,” University World News reports.
- A study tying “police killings of unarmed black people with health problems in black infants has been retracted due to problems with the data.”
- “Boston Scientific Corp. must complete a $275 million buyout of Channel Medsystems Inc., a judge said, ruling the deal couldn’t be canceled just because a former Channel executive submitted false data to federal regulators about its flagship product.”
- “There’s No Winter Break From ‘Publish or Perish.’”
- “Our results show that removing impact factors from evaluation does not negate the influence of journals.”
- “Facing public pressure to rein in its pollution, a Japanese chemical manufacturer has instead launched an aggressive, years-long campaign to undermine the science showing that its compounds could cause cancer, according to newly released documents reviewed by the Guardian.”
- “Joelle Pineau doesn’t want science’s reproducibility crisis to come to artificial intelligence (AI).”
- “It is likely that improving chair training in the management of discussion as well as creating review procedures that are informed by the science of leadership and team communication would improve review processes and proposal review reliability.”
- “Justice Department investigates Sci-Hub founder on suspicion of working for Russian intelligence.”
- More than 100 scientific societies have warned the Trump administration not to change rules on publishing embargoes that would make all papers deriving from government-funded research immediately free.
- “As a result, one may argue that over the past 20 years, tenure policies have helped develop research excellence of China’s higher education, but at the expense of the quality of teaching and service.”
- “This practice of listing co-authors alphabetically, along with the privileging of the first author, may disadvantage minority group members, whose names often appear later in the alphabet than white scholars.”
- “Kenya’s Commission for University Education (CUE) is developing criteria according to which it will evaluate academic journals produced by universities, in what it says is a step towards regulating publications and ensuring their quality.”
- The Belgrade University Senate unanimously declared Serbia’s Finance Minister Sinisa Mali’s doctorate as plagiarism and annulled it.
- “An Army deputy chief of staff has been retired at a lower rank after a watchdog investigation found he had plagiarized…”
- “Women were 12.3% less likely than men to frame their work with positive words like ‘novel’ or ‘excellent’ in abstracts,” says a new study.
- “This summer, I killed a bird while on a research trip.” A graduate student reflects on ethics in research.
- “Of course, there are things that we can’t tell you and make completely public, like the way we will detect potential misconduct. If you specify the means you apply to detect issues, you allow people to avoid detection.”
- “A retraction, for even stronger reasons, would be wrong. That would be saying to a reader or viewer: ‘Forget about what you read in the past; it never happened.'”
- An academic whose paper in a Taylor & Francis journal linking the HPV vaccine to reduced pregnancy rates was just retracted says, on a site known for pushing the false vaccines cause autism narrative, that one of T&F’s journals just asked her to peer review another paper.
- “[W]hen assessing potential retractions, demonstrating conscious culpability is not a mandatory requirement.” Another look at the Hans Eysenck case.
- “What publishing as a lead author has taught me: Four scientists reveal their key lessons from the publication process.”
- “Is N-hacking ever OK?”
- “Many researchers, me included, find the idea that you should only publish in certain venues limiting, frustrating and fraught with problems.”
- “As raised on PubPeer, there is image duplication in Figure 2. Further issues were found with the figures and reporting, including when compared with the thesis of the first author.” An extensive retraction notice.
- “Peer-review for six-year-olds:” A “Groundbreaking journal unearths new talent.”
- “There is a prevalent myth that peer review began fully formed in the seventeenth or early eighteenth century,” says Mark Hooper. “This is false.”
- “Here’s what happens when you report plagiarism to a journal editor.”
- “What is the point of reading a paper if you have to contact the authors for all of the details that you would actually need to reproduce their original study?”
- “Basically, as long as scientists are willing to transform research into a business – i.e. by setting up journals of any kind, open-access or not – high impact journals will indirectly benefit.”
- A journal “accepted the research paper from ‘Andrra Qielli,’…a professor at Triumph University in Tirana, which does not exist.”
Like Retraction Watch? You can make a tax-deductible contribution to support our work, follow us on Twitter, like us on Facebook, add us to your RSS reader, or subscribe to our daily digest. If you find a retraction that’s not in our database, you can let us know here. For comments or feedback, email us at [email protected].
“A retraction, for even stronger reasons, would be wrong. That would be saying to a reader or viewer: ‘Forget about what you read in the past; it never happened.’”
The Sentinel Source this links to is such a privacy problem that they have opted not to have an internet presence in Europe and block any reader from the EU because they cannot comply with EU privacy laws.
“451: Unavailable due to legal reasons
We recognize you are attempting to access this website from a country belonging to the European Economic Area (EEA) including the EU which enforces the General Data Protection Regulation (GDPR) and therefore access cannot be granted at this time.“
Trump should be careful about setting a precedent regarding products of federally funded research, lest he destroy the private biotech industry. Many (most?) biotech companies are built on patents and products developed through federally funded research. If we argue that all federally funded data should be immediately free, couldn’t we extrapolate to say that all products/inventions/IP from federally funded research should be free too? After all, a paper is a research product just like an invention.
He can’t repeal Bayh-Dole with an executive order.
Like most things that are Trump related, this rumor has caused instant derangement of otherwise reasonable people. Your reductio ad absurdum extrapolation is particularly strange since
1) Not that it matters, but I’m willing to bet that biotech companies will support it.
2) The rumored policy would simply be an American version of “Plans S”, already supported by science centers and research councils across Europe, and I have yet to hear about IP laws going out the window.
3) In 2013 the Obama administration were going for (but never implemented) the same policy, so it must be okay.
https://obamawhitehouse.archives.gov/blog/2013/02/22/expanding-public-access-results-federally-funded-research
By the way, the Obama administration did implement something. It’s called the 12 month embargo, and it works just fine.
Couple things: You’ve assumed that my argument came from a political prejudice, and in so doing you immediately revealed yours. Thus, all your credibility is lost. In fact, my concern is that the bill will be paid by researchers, since nearly all open access journals require the researchers themselves to pay up. That will be one more drain on already strained research budgets. The difference with Plan S is that the stakeholders agreed on a timeline so alternative routes to keep the journals funded could be mapped out. An executive order would likely be effective immediately, or would leave the details of a plan in the hands of Trump. Finally, once a precedent is set, the doors could be open for a commotion related to Bayh Dole, though I’ll admit that would be a hard sell.
The paper was a little different, but I have been hesitant to post on PubPeer (since it is outside my normal research, and I thought that might have more of a negative connotation then a regular comment).
However, if there is a discussion about Fatal Encounters database, I did notice some differences between these sources:
Fatal Encounters: https://fatalencounters.org/our-visualizations/
Washington Post Police Shootings: https://www.washingtonpost.com/graphics/2019/national/police-shootings-2019/
In a sense, perhaps having different sources helps give a sense of the range of estimates. However, in absolute terms, you may notice some differences.
I also tried to use these resources to get a relative sense of the incidence for death from police versus other causes:
https://www.cdc.gov/nchs/pressroom/sosmap/homicide_mortality/homicide.htm
https://www.cdc.gov/nchs/fastats/deaths.htm